Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A link between protein translation and body weight
Liangyou Rui
Liangyou Rui
Published February 1, 2007
Citation Information: J Clin Invest. 2007;117(2):310-313. https://doi.org/10.1172/JCI31289.
View: Text | PDF
Commentary

A link between protein translation and body weight

  • Text
  • PDF
Abstract

Nutrient overload induces obesity, a primary risk factor for type 2 diabetes. Ribosomal biogenesis and protein synthesis, which are controlled by the mammalian target of rapamycin (mTOR), are primary energy-consuming processes in cells. mTOR phosphorylates and inactivates members of the eukaryotic translation initiation factor 4E–binding (eIF4E-binding) protein (4E-BP) family, which are translational repressors of 5′ cap–dependent protein synthesis. In this issue of the JCI, Le Bacquer et al. report that simultaneous deletion of both 4E-BP1 and 4E-BP2 in mice results in insulin resistance, decreased energy expenditure, and increased adipogenesis (see the related article beginning on page 387). These findings link protein synthesis, insulin sensitivity, and body weight.

Authors

Liangyou Rui

×

Figure 1

A model of the regulation of body weight and insulin sensitivity by mTOR, S6K1, and 4E-BP.

Options: View larger image (or click on image) Download as PowerPoint
A model of the regulation of body weight and insulin sensitivity by mTOR...
Nutrients and hormones stimulate the association of mTORC1 with eIF3. mTORC1 phosphorylates eIF3-associated S6K1 at Thr389. Phosphorylated S6K1 is dissociated from eIF3 and subsequently phosphorylated and activated by PDK1. S6K1 phosphorylates eIF4B, increasing the ability of eIF4B to enhance eIF4A helicase activity. S6K1 phosphorylates IRS-1, inhibiting insulin signaling. S6K1 phosphorylates mTOR, which may decrease the abundance of mTORC2 and/or the ability of mTORC2 to phosphorylate Akt at Ser473, contributing to insulin resistance. A separate pool of mTORC1 may phosphorylate 4E-BP at multiple sites, resulting in dissociation of eIF4E from 4E-BP. 4E-BP–free eIF4E binds to eIF4G that is associated with both eIF4A and eIF3. eIF3 binds to the 40S ribosomal subunit and recruits the 40S subunit to the 5′ cap. eIF4A, assisted by eIF4B, unwinds the secondary structure in the mRNA 5′ UTR, facilitating the assembly of a translation initiation complex. The data reported in this issue by Le Bacquer et al. (1) suggest that reduced expression of 4E-BP increases the pool of mTORC1 that phosphorylates and activates S6K1. These data also raise the possibility that genetic modifiers and nutrients may modify the ability of 4E-BPs to repress the translation of key regulators of energy conservation and combustion programs, thereby regulating adiposity and body weight, which indirectly modulate insulin sensitivity. GβL, G protein β subunit–like protein; m7GpppN, the 5′ cap structure; mSin1, mammalian stress-activated protein kinase interacting protein 1; Raptor, regulator-associated protein of mTOR; Rictor, rapamycin-insensitive companion of mTOR.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts